Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is focused on improving the early detection and management of cancer and other chronic diseases through diagnostics telehealth programs. Its lead product, Aristotle, is a mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. The Care Oncology Clinic offers a supervised treatment regimen for people diagnosed with cancer of any type or stage. AVRT is a physician-led, telehealth program for identifying and managing the early warning signs of cancer and chronic disease. Its program includes a comprehensive online health evaluation; bloodtests to measure markers of inflammation and metabolism; an initial physician consultation; regular physician follow-up appointments and interval screening. Its additional cancer diagnostics include ColonSentry and the Prostate Health Index.


TSX:SZLS - Post by User

Post by StockscoutXon Mar 06, 2021 10:07am
231 Views
Post# 32735886

From SEDAR Mar 4 2021, 13:36:50 ET

From SEDAR Mar 4 2021, 13:36:50 ETTSX TRUST COMPANY
VIA ELECTRONIC TRANSMISSION

TO ALL APPLICABLE EXCHANGES AND COMMISSIONS:

RE:STAGEZERO LIFE SCIENCES LTD.
Confirmation of Notice of Record and Meeting Dates.

We are pleased to confirm that Notice of Record and Meeting Dates was sent to The Canadian Depository forSecurities.

We advise the following with respect to the upcoming Annual and Special Meeting of Security Holders for thesubject issuer:

1) ISIN : CA8525403017
CUSIP : 852540301

2) Date Fixed for the Meeting : May 17, 2021

3) Record Date for Notice : March 29, 2021

4) Record Date for Voting : March 29, 2021

5) Beneficial Ownership Determination Date : March 29, 2021

6) Classes or Series of Securities that entitle the holder to receive Notice of the Meeting : COMMON

7)
Classes or Series of Securities that entitle the holder to vote at the meeting : COMMON

8) Business to be conducted at the meeting : Annual and Special

9) Notice-and-Access :
Registered Shareholders : YES
Beneficial Holders : YES
Stratification Level : Not Applicable

10) Reporting issuer is sending proxy-related materials directly to Non-Objecting Beneficial Owners : YES

11) Issuer paying for delivery to Objecting Beneficial Owners : YES

Yours truly,

TSX Trust Company

"Christopher de Lima "Senior Relationship Manager
Christopher.delima@tmx.com
<< Previous
Bullboard Posts
Next >>